These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29281870)

  • 1. Histopathological evaluation of liver fibrosis and cirrhosis regression.
    Lo RC; Kim H
    Clin Mol Hepatol; 2017 Dec; 23(4):302-307. PubMed ID: 29281870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.
    Hytiroglou P; Theise ND
    Virchows Arch; 2018 Jul; 473(1):15-22. PubMed ID: 29589101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversibility of hepatic fibrosis].
    van der Meer AJ; Sonneveld M; Schouten JN; Janssen HL
    Ned Tijdschr Geneeskd; 2014; 158():A6790. PubMed ID: 24594125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Regression of Cirrhosis.
    Saffioti F; Pinzani M
    Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
    Jin SY
    Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving strategies for liver fibrosis staging: Non-invasive assessment.
    Stasi C; Milani S
    World J Gastroenterol; 2017 Jan; 23(2):191-196. PubMed ID: 28127192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive markers and predictors of severity of hepatic fibrosis in HCV patients at Sharkia Governorate, Egypt.
    el-Shorbagy E; Afefy AF; Ibrahem IA; Mangoud AM; Eissa MH; Sabee EI; Mahrous S; Abdel-Monem A; Ismail A; Morsy TA; Etewa S; Nor Edin E; Mostafa Y; Abouel-Magd Y; el-Sedawy M; Ragab H; el-Tokhy H; Hassan MI; Lakouz K; Abdel-Aziz K; el-Hady G; Saber M
    J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):459-78. PubMed ID: 15124753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical Guide, Challenges, and Pitfalls in Liver Fibrosis Staging.
    Matsukuma K; Yeh MM
    Surg Pathol Clin; 2023 Sep; 16(3):457-472. PubMed ID: 37536882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances in the treatment of hepatic fibrosis].
    Xia L; Yang CQ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):566-570. PubMed ID: 29056004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver cirrhosis.
    Pinzani M; Rosselli M; Zuckermann M
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized Mouse Models for Liver Fibrosis.
    Kim YO; Popov Y; Schuppan D
    Methods Mol Biol; 2017; 1559():279-296. PubMed ID: 28063051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging diagnosis of cirrhosis and chronic hepatitis.
    Ito K; Mitchell DG
    Intervirology; 2004; 47(3-5):134-43. PubMed ID: 15383722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fibrosis: the good, the bad, and the patchy-an update.
    Guindi M
    Hum Pathol; 2023 Nov; 141():201-211. PubMed ID: 36702358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.